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Abstract
Background and methods: Little is understood about why few women during the perinatal period will use de-
pression treatment. In particular, beliefs and barriers related to depression treatment use have not been stud-
ied. In this study, African American and white pregnant women (n  108) who screened 10 on the Edinburgh
Postnatal Depression Scale (EPDS) were asked about recent formal and informal treatment use in prenatal care
settings. Confidence in the helpfulness of treatment, providers, and settings and perceived barriers to treatment
were assessed and compared between African American and white women.
Results: Pregnant women overall reported low rates of formal treatment use but frequently sought help from
informal sources, such as friends, family, and printed materials. All women expressed greatest confidence in
psychosocial treatments and lowest confidence in antidepressants. African American women reported less con-
fidence in advice from family and friends and in antidepressants than did white women. Women expressed
greatest confidence in treatments delivered by mental health professionals and religious leaders. African Amer-
ican women sought help more frequently and had significantly more confidence in religious leaders as treat-
ment deliverers than white women. Women had greatest confidence in treatments delivered in professional
and home settings, with African American women expressing greater confidence in religious settings than white
women. All women reported greatest concern with structural barriers, compared with attitudinal and knowl-
edge barriers.
Conclusions: Understanding patterns of treatment use, beliefs, and barriers to depression treatment provides
important information for tailoring and improving appropriate use of mental health treatment in women dur-
ing the perinatal period.
1301
Introduction
AGREAT DEAL OF RECENT national attention has focused onboth treatment issues for perinatal depression1 and racial
disparities in mental health treatment.2–4 Despite the fact that
close to 1 in 4 women may experience depression during the
perinatal period, most are unlikely to receive effective treat-
ments.5 African American women are less likely to seek de-
pression treatment than are white women.6,7 Evidence of preg-
nancy and birth complications associated with untreated
depression points to the need for research addressing factors
underlying low treatment rates among depressed women
around the time of childbirth, as well as racial differences in
these factors. Results from the National Institutes of Mental
Health Sequenced Treatment Alternatives to Relieve Depres-
sion (NIMH STAR-D) study further highlight the importance
of effective treatment of maternal depression by demonstrat-
ing changes in children’s mental health diagnoses and symp-
toms associated with maternal depression remission.8 Other
recent studies and Food and Drug Administration (FDA) ad-
visories regarding possible fetal risk associated with antide-
pressant medications during pregnancy may lead to confusion
about safe and effective treatments for perinatal depression.9–11
Given women’s vulnerability to depression and the dual im-
pact it has on both women and their children during the peri-
natal period, it is especially important to understand factors
guiding women’s treatment choices during this time in order
to improve rates of effective treatment. The present study
aimed to add to the literature by examining women’s beliefs
about treatment and their perceived barriers to receiving treat-
ment and to examine racial and socioeconomic differences in
these treatment-related issues.
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To date, little is known about factors involved in depressed
women’s decisions to use treatment, particularly during preg-
nancy and the postpartum period. Research in this area has
focused primarily on structural factors (such as low socioeco-
nomic level and lack of transportation) on poor treatment
use.12,13 A recent study by Flynn et al.,5 however, found low
rates of treatment use among a sample comprising primarily
insured, relatively highly educated pregnant women with de-
pression. In that study, low treatment rates for depression
were found despite the fact that all women had access during
their obstetrics visit to a mental health clinician offered at no
fee. That study and others points to the need to broaden our
understanding of factors involved in women’s use of mental
health treatment. Emerging research has demonstrated that
decisions to use treatment are impacted by both prompts and
barriers to mental health treatment use.14 Individual beliefs
may be a critical prompt for treatment.3,4,15 Positive treatment
beliefs have been linked with increased mental health treat-
ment use.16,17 Conversely, individuals who endorse beliefs
that treatment would be of little help are less willing to seek
mental health treatment.18 Confidence about individual
change has also been shown to predict depression treatment
adherence in general patient populations.19
Little is known, however, about women’s beliefs about the
helpfulness of mental health treatment around the time of
pregnancy. Two studies to date have investigated women’s
treatment preferences in low-income, public health clinic ob-
stetrics/gynecology settings. Alvidrez and Azocar20 found
that women were broadly interested in receiving mental
health treatment, expressing greatest interest in psychother-
apy and psychoeducation about health and stress and least
interest in medication or group therapy. In a similar sample,
highlighting the importance of understanding both formal
and informal mechanisms of treatment use, Scholle and
Kelleher21 reported that 33% of women preferred informa-
tion about mental health issues from informal sources (e.g.,
printed material, friends), and 5% did not want any advice
about mental health. In that study, those who did want men-
tal health advice (63%) from formal sources (any health pro-
fessional) indicated that they most preferred to receive that
advice from an obstetrician/gynecologist (23%), mental
health professional (25%), or general medical doctor (14%).
These results suggest that beliefs about the helpfulness of
treatment may have a strong role in understanding mental
health treatment use. Such investigations are particularly
salient for racial or ethnic minorities, where there are often
widely disparate rates of mental health use and a greater risk
for persistent symptoms.2,22 For example, in one qualitative
study, African American women expressed strong prefer-
ences for receiving help from religious sources and reported
believing that traditional mental health services were not in-
tended for them.23 African Americans have also reported
finding medication treatment less acceptable, expressing a
preference for counseling.24,25 Understanding how beliefs
vary across racial groups is, therefore, potentially critical to
improving women’s access to and use of depression treat-
ment.
Even when positive beliefs about treatment are expressed,
barriers to treatment may interefere with actual treatment
use.14,26 In addition to structural barriers, recent research has
highlighted the role of negative attitudes and lack of knowl-
edge about depression in poor treatment use.14,26,27 Reviews
of the literature suggest that concerns about how others per-
ceive depression (e.g., to be a personal weakness)23 are par-
ticularly salient factors in depression treatment use among
racial minorities.7,28,29
Although this growing body of research highlights the role
of beliefs about the helpfulness of treatment and perceived
barriers in predicting actual treatment use, few studies have
examined these factors during the perinatal period. The peri-
natal period merits specific focus, as depressed women may
experience unique physical and psychological demands as a
consequence of pregnancy and childbirth. These demands
may, in turn, alter women’s confidence and perceived bar-
riers regarding mental health treatment. For example,
women may likely find antidepressant treatment less ac-
ceptable, given that pregnant and breastfeeding women of-
ten are concerned about the impact of medication on the fe-
tus.20,30 Women suffering from perinatal depression may
also have unique concerns about barriers to treatment. For
instance, women have reported reluctance to admit to their
low mood because of feelings of guilt and stigma about be-
ing depressed during a time society regards as a happy pe-
riod.31 In one study, depressed pregnant women who re-
fused psychotherapy reported they did so because they were
“not depressed enough” or “did not want to be labeled.”32
Women suffering from perinatal depression may also expe-
rience more trouble with transportation or difficulty access-
ing treatment because of child care concerns.
The present study examined psychological factors im-
pacting pregnant women’s use of mental health treatment
among a group of pregnant women who scored 10 on the
Edinburgh Postnatal Depression Scale (EPDS). Women’s for-
mal and informal mental health treatment use in the 6
months prior to their participation in the study was exam-
ined. In addition, both confidence in the helpfulness of treat-
ment and perceived barriers to treatment were investigated.
This study extended previous research on mental health
treatment use during pregnancy by examining both formal
(mental health professional) and informal (discussed with
family) mental health treatment. Further, this study builds
on previous research on beliefs about and preferences for de-
pression treatment19 by investigating pregnant women’s be-
liefs about their confidence in the helpfulness of treatment
for depression treatment along three dimensions: treatment
type (e.g., seeking social support, antidepressant medica-
tion), treatment provider (e.g., obstetrician, mental health
professional), and treatment delivery mode (e.g., profes-
sional office, internet). Consistent with research suggesting
that attitudinal, structural, and knowledge factors are par-
ticularly relevant barriers to treatment,14 we examined
women’s relative endorsement of these three barriers. An im-
portant aim of this study was to examine differences in be-
liefs and barriers to treatment between African American
and white women in the study sample.
Materials and Methods
Participants and procedures
Eligible women were recruited in the waiting rooms of
four Midwestern area obstetrical/gynecological clinics in the
United States between 2004 and 2007. One of the clinics was
associated with a university hospital in a suburban setting.
The other three clinics were part of a nonprofit organization
focused on treating underserved populations in urban set-
tings. The samples from the suburban and urban clinics were
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ethnically and socioeconomically representative of the pop-
ulations from which they were drawn (Table 1, U.S. Bureau
of the Census, 2005).
All women were approached by research assistants in the
waiting area, told about the study, and provided informed
written consent. To be eligible for the study, women had to
be 18 years, currently pregnant, and seeking prenatal care.
Of the 532 women approached, 84% (n  447) were eligible
for the study based on these criteria and consented to com-
plete the screening survey. Reasons for nonparticipation in-
cluded not eligible, 6% (n  32) and not interested/not
enough time, 10% (n  53). The screening survey included
the following measures: the EPDS,33 one question assessing
past depression (Has there ever been a period, at any point
in your life, where you felt depressed, irritable, or lost in-
terest in pleasurable activities and had some of the symp-
toms listed above nearly every day for a period of at least 2
weeks?), and four questions assessing current social stress
on a 5-point Likert scale ranging from “not at all” to “ex-
tremely” (How “stressed” have you felt in the past 2 months?
How much conflict have you had with those whom you care
about in the past 2 months? When you experience prob-
lems/stress, to what extent to do you feel you can seek out
support from those whom you care about? When you expe-
rience problems/stress, to what extent do you seek out sup-
port from those whom you care about?). These items were
adapted from current research on stress and social support,
which has demonstrated a strong link between perceived
stress and interpersonal conflict and the onset of depres-
sion.34,35
Measures of demographics, including age, socioeconomic
level, and race, were also included in the screen. Women who
(1) scored 10 on the EPDS or (2) indicated that they suf-
fered from past depression and were experiencing signifi-
cant current stress (operationally defined as a summed score
of 4 on the social stress scale) were determined to be eli-
gible for a baseline interview. These inclusion criteria for the
baseline interview were selected based on previous research
showing that pregnant women with scores of 10 on the
EPDS or a history of depression and current social stress (or
both) are at risk for developing clinical depression.36–38
Of the women who consented to participate in the study
(n  447), 39% (n  174) were determined to be at risk for
depression. (Depression risk is subsequently defined as
“EPDS score 10 or greater, or having experienced past de-
pression and currently undergoing significant social stress,
defined as a score of 4 or greater on the social stress ques-
tions.”) The loss to the study of women in our risk group
who miscarried during the course of the study (2%, n  3),
were not able to be contacted despite multiple attempts (32%,
n  56), or declined further participation (4%, n  7) resulted
in a total depression risk sample of 108. This rate of attrition
is typical for studies involving similar innercity samples.39,40
Eligible women were contacted via telephone within 3 weeks
of their screening visit and asked to complete an interview.
The interview included measures of depression severity, use
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TABLE 1. DEMOGRAPHICS
Overall Suburban Urban
Variable % (n) [or Mean (SD)]*
Age,a years
18–27 59.6 (65) 36.5 (40) 75.0 (81)
28–42 40.4 (43) 43.5 (48) 25.0 (27)
Race
African American 51.0 (55) 6.3 (6) 68.3 (73)
White 40.8 (53) 78.0 (84) 28.6 (31)
Incomea
0–$19,999 45.0 (49) 8.4 (9) 74.1 (80)
Health insurance
Private insurance 24.5 (26) 50.0 (54) 8.8 (10)
Medicaid 65.3 (70) 20.5 (23) 80.0 (86)
No insurance 4.1 (4.3) 2.0 (2) 3.1 (3)
Marital statusa
Married 44.9 (49) 83.0 (90) 15.1 (16)
Live-in partner 22.4 (24) 13.3 (14) 42.8 (46)
Not in a relationship 28.6 (31) 1.3 (1) 40.3 (43)
How many children (not including pregnancy)a 1.82 (1.78) 1 (1.04)* 1.32 (1.30)
Weeks pregnant
0–12 15.1 (16) 39.4 (42) 19.7 (22)
13–24 42.3 (45) 24.5 (27) 37.6 (41)
25–40 42.4 (45) 35.1 (38) 42.7 (46)
Educationa
Less than high school 21.3 (23) 7.0 (8) 35.6 (39)
High school/GED 28.6 (31) 12.7 (15) 32.5 (36)
More than high school 46.8 (51) 80.1 (86) 31.9 (35)
Current work status
Homemaker 50.0 (54) 34.4 (38) 37.3 (40)
Employed 21.7 (24) 58.0 (63) 27.5 (30)
aSignificant racial differences.
of mental health services, preferences for mental health treat-
ment, and barriers to treatment. Interviews lasted approxi-
mately 1 hour and were conducted via telephone (55%, n 
59) or in the woman’s home (45%, n  49), based on the
woman’s preference.
Measures
Edinburgh Postnatal Depression Scale. The 10-item EPDS
was used as the depression screening tool in this study.33
Originally developed to assess postpartum symptoms, the
EPDS has also been validated in prenatal samples.36 Using
a cutoff score of 10, the EPDS has a sensitivity of 90% and
specificity of 78%–88% for the identification of both minor
and major depression.1,36 Previous research with similar
samples of pregnant women has found that when using a
cutoff of 10, 74% of women met diagnostic criteria for de-
pression using the Mood Disorders Module of the Structured
Clinical Interview for DSM-IV (SCID).5
Depression treatment use. Depression treatment use was
measured with items assessing formal specialty depression
treatment services (e.g., How many times have you met or
spoken with a mental health professional about your mood
in the last 6 months?), including information about locations
(e.g., inpatient, outpatient, community mental health center)
and providers (e.g., psychiatrists, social workers, psycholo-
gist, nurses). Analyses of data from this questionnaire fo-
cused on whether or not participants sought treatment for
depression (medication or counseling/psychotherapy) at
any point during the study period. Treatment use was coded
as a binary variable (yes/no) based on whether participants
reported using antidepressant medication or counseling/
psychotherapy during the 6 months leading up to and in-
cluding the date of the baseline interview. Women were also
asked about the frequency with which they sought out for-
mal and informal treatment sources during the previous 6
months (e.g., How frequently have you spoken to someone
in your family about your mood [depression]?). Responses
were coded on a 5-point Likert scale (range 1, never, to 5,
very often).
Confidence in helpfulness of mental health treatment.
Women were asked to indicate their confidence in the help-
fulness of mental health treatment across setting, provider,
and treatment type. Participants were asked to choose which
provider, setting, and treatment type they preferred from a
list of choices (e.g., mental health specialist, primary care
physician, obstetrician). They were then asked to indicate on
a 5-point Likert scale how confident they were that each per-
son, setting, and treatment type could help them with their
depression (range 1, not at all confident, to 5, very confident).
Barriers to treatment. Barriers to seeking treatment were
assessed, using a study-specific measure, along three di-
mensions supported by the literature linking perceived bar-
riers to mental health treatment: attitudinal, knowledge, and
structural.14,26 Items comprising the structural barriers scale
were adapted from the work of Scholle et al.12 examining
women’s perceived structural barriers to treatment. Attitu-
dinal and knowledge items associated with depression treat-
ment use were adapted from studies examining use of treat-
ment in depressed samples (see Appendix for list of items).
Items were assessed using a 5-point Likert scale (“not at all”
to “completely”) querying women about the extent to which
each item prevented them from seeking treatment for de-
pression.
Data plan
Descriptive analyses (means and frequencies) of rates of
treatment use, women’s treatment preferences, and per-
ceived barriers to treatment were performed first. Differ-
ences in demographic data by race, socioeconomic level, and
depression were calculated using Chi-square. Consistent
with previous research investigating depressed individual’s
use of mental health treatment,5,19 the data on women’s for-
mal and informal treatment use within the past 6 months
and their confidence for the helpfulness of treatment were
positively skewed. Square root transformations normalized
the data for mean scores on measures of women’s treatment
history and confidence in the helpfulness of treatment. Dif-
ferences in African American and Caucasian women’s over-
all use of formal (mental health professional, medical
provider) and informal (family/friends, printed material, in-
ternet, religious leader) mental health treatment use were an-
alyzed with MANOVA. One-way post-hoc ANOVAs were
used to examine differences in specific types of treatment
sought (e.g., family/friend support). Differences between
African American and Caucasian women’s confidence in rat-
ings of the helpfulness of treatment and their perceived bar-
riers to treatment were analyzed with two sample t tests.
Paired t tests were used to examine differences between all
women’s perceived concerns with barriers to treatment.
Results
Participant information
Four hundred forty-seven obstetrical patients initially
completed the screening measures described. Rates of
women recruited from the different clinic sites were closely
equivalent; 41% (n  187) of the total sample were recruited
from the suburban clinic, and 49% (n  260) were recruited
from the urban clinics. Participant demographics by clinic
are listed in Table 1. The suburban clinic sample comprised
primarily white (86%, n  160) and upper middle class (me-
dian family income $100,000) women. Women from the ur-
ban clinics were primarily African American (57%, n  148)
and living below national poverty levels (87%, n  226).
Rates of consent did not differ significantly between clinic
sites, socioeconomic level and race.
African American women (chi-square (1)  7.23, p  0.01)
were more likely than white women to complete the base-
line interview. There were no other significant demographic
differences between women who completed the interview
and those who did not (included variables: age, weeks preg-
nant, marital status, years of school, work status, socioeco-
nomic status, clinic site). African American women were sig-
nificantly younger than white women (chi-square (5) 
26.35, p  0.001). Although most women were in a commit-
ted relationship (63%, n  64), African American women
were more likely to be single (chi-square (4)  20.68, p 
0.01) and to have more children than white women (chi-
square (1)  4.49, p  0.05). African American women in the
sample had also obtained less education (chi-square (7) 
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36.39, p  0.01) and were more likely to be living in poverty
than white women, (chi-square (1)  48.86, p  0.001).
Of the women screened overall, 39% (n  174) met crite-
ria for risk for depression. The mean (M) EPDS score among
the women who screened at risk (EPDS score 10 or indi-
cation of past depression and current social stress) was 15.41
(SD 4.45).
Treatment use history
Only 12% (n  13 of 108) of the interviewed sample re-
ported having any formal treatment by a medical provider
or mental health professional in the 6 months prior to their
baseline interview. (These results were replicated with a sub-
sample of at-risk women limited to only those who had
scored 10 on the EPDS (n  97). Only 12% (n  12) of those
women had sought any kind of treatment.) However 52%
(n  56 of 108) of women indicated having used informal
methods for support and information. Women’s rank-or-
dered results, by race, regarding the frequency of mental
health contact are shown in Table 2, indicating that women
most frequently sought advice from family and friends and
were least likely to turn to community/religious leaders,
mental health professionals, and the internet. MANOVA re-
sults indicated there were no significant racial differences in
rates of formal treatment use (mental health professional,
medical provider), lambda (2, 106)  0.99, NS. There were,
however, significant differences in African American and
white women’s rates of informal treatment use, lambda (5,
103)  0.87, p  0.05. Post-hoc ANOVAs demonstrated that
African American women (M  1.38, SD  0.11) were more
likely to have spoken to a religious leader about mood than
were white women (M  1.05, SD  0.12), F (1)  4.20, p 
0.05.
Confidence in helpfulness of mental health treatment
As women’s willingness to seek treatment may be guided
by their beliefs about what treatments are helpful, all women
were asked about the extent to which they had confidence
in provider, treatment, and delivery type. Women’s reported
confidence, including racial differences in their confidence
for each subcategory, is shown in Table 3. Regarding
provider type, women reported having the greatest levels of
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TABLE 2. RACIAL DIFFERENCES IN MENTAL HEALTH ADVICE AS RECENTLY SOUGHT BY
WOMEN AT RISK FOR DEPRESSION
Endorsed African American White
Source % (n) Mean (SD) Mean (SD)
Treatment use in previous 6 months
Family 52 (56) 2.04 (1.30) 2.52 (1.27)
Friends 44 (48) 2.22 (1.36) 2.19 (1.37)
Printed material 40 (43) 1.84 (1.02) 1.64 (.82)
Medical provider 36 (40) 1.71 (1.04) 1.60 (.94)
Internet 14 (15) 1.24 (.80) 1.21 (.57)
Religious leader 10 (11) 1.38 (1.01) 1.60 (.94)
Mental health professional 12 (13) 1.33 (.91) 1.17 (.62)
TABLE 3. RACIAL DIFFERENCES IN WOMEN’S REPORTED CONFIDENCE IN TREATMENT
African 95%
Endorsed American White Confidence
Source % Mean (SD) Mean (SD) t df Significance interval
Confidence in provider
Mental health specialist 85.1 3.31 (1.43) 3.47 (1.18) 0.81 107 0.42 0.69 0.37
Pastor 60.5 3.45 (1.23) 2.79 (1.27) 2.34 107 0.02 0.03 3.60
Primary care physician 68.8 2.86 (1.26) 2.90 (1.10) 0.32 107 0.75 0.18 0.13
Obstetrician/gynecologist 62.5 2.61 (1.34) 2.69 (1.15) 0.46 107 0.64 0.20 0.13
Community liaison 29.2 2.04 (1.24) 2.00 (0.92) 0.16 107 0.88 0.17 0.14
Child’s pediatrician 33.3 1.80 (1.21) 1.89 (1.07) 0.56 107 0.58 0.21 0.12
Confidence in treatment helping
Therapy 76.4 3.18 (1.41) 3.19 (1.32) 1.1 107 0.27 0.21  0.060
Family/friend support 89.6 3.12 (1.2) 3.52 (1.03) 1.75 107 0.08 0.27 0.02
Antidepressant 68.7 2.42 (1.3) 3.04 (1.2) 2.57 107 0.01 0.38 0.05
Case management 62.5 2.35 (1.38) 2.60 (1.16) 1.18 107 0.24 0.27 0.07
Confidence in treatment delivery locale
Professional office 91.7 3.24 (1.33) 3.96 (1.03) 2.91 107 0.01 0.37 0.07
Home 68.8 3.47 (1.39) 3.25 (1.43) 0.72 107 0.48 0.11 0.24
Religious setting 60.4 3.45 (1.21) 2.85 (1.35) 2.28 107 0.03 0.02 0.35
Telephone 45.8 2.10 (1.16) 2.56 (1.46) 1.60 107 0.16 0.31 0.03
Community setting 35.4 2.00 (1.19) 2.13 (1.35) 0.40 107 0.70 0.21 0.14
Internet 27.1 1.47 (0.92) 1.96 (1.30) 2.16 107 0.03 0.32 0.13
confidence in treatment received from a mental health spe-
cialist or pastor, followed by medical professionals (e.g., pri-
mary care physician, obstetricians/gynecologists). African
American women expressed significantly greater confidence
in treatment delivered by a pastor than did white women.
Women also expressed high levels of confidence in treat-
ments that were psychosocially based. Specifically, therapy
and support from family received the highest rankings of
confidence. Case management and antidepressants were
ranked lowest in terms of expressed confidence. African
American women were significantly less likely to report con-
fidence in family or friend support and in antidepressants
helping them with their mood symptoms than were white
women. Lastly, women reported high levels of confidence in
treatments delivered in professional and home settings and
expressed low levels of confidence in the helpfulness of treat-
ments delivered in community settings (e.g., a neighborhood
center, library) or via the internet. However, African Amer-
ican women expressed less confidence in treatments deliv-
ered in a professional setting than did white women. African
American women also had particularly low ratings of confi-
dence in treatments delivered via the internet in comparison
to white women. In contrast, African American women ex-
pressed more confidence in treatments delivered in a reli-
gious setting than did white women.
Treatment barriers
Women’s reported concerns with barriers to mental health
treatment use were examined. Women reported more con-
cern with structural barriers (M  10.56, SD  5.56) as com-
pared with knowledge (M  7.43, SD  3.32, t (107)  5.31,
p  0.003) and attitudinal (M  6.95, SD  4.62) barriers
(t(107)  6.61, p  0.000). There were no significant overall
differences in women’s expressed concerns with knowledge
and attitudinal barriers. Women’s mean rankings of struc-
tural barriers of greatest concern were as follows: insurance
(M  2.56, SD  1.78), inability to pay (M  2.23, SD  1.52),
transportation (M  2.16, SD  1.50), and inadequate child
care (M  2.07, SD  1.35). Within knowledge barriers,
women were least sure whom to contact (M  2.16, SD 
3.25) and did not know the best treatment for their depres-
sion (M  2.06, SD  1.26). Finally, women’s greatest attitu-
dinal barriers were their lack of expressed motivation for
treatment (M  2.06, SD  1.17) and hopelessness about
treatment working (M  1.80, SD  1.16). There were no sig-
nificant differences in the extent to which African American
and white women endorsed difficulties with structural,
knowledge, or attitudinal barriers.
Discussion
The primary aim of this study was to examine women’s
beliefs and barriers to depression treatment during the peri-
natal period. In addition, given differential rates of depres-
sion treatment use between African American and white
women, this study sought to explore racial differences in
women’s beliefs and barriers to treatment.
The current study found high rates of elevated EPDS
scores and histories of past depression. The majority of
women who had experienced previous depressive symp-
toms also endorsed current elevated depressive symptoma-
tology. Consistent with previous research, few women in-
terviewed had sought any kind of formal treatment.5 Those
who did seek treatment were most likely to have spoken to
their medical provider and least likely to have spoken with
a mental health provider. Other research in this area has
found that previous contact with a mental health profes-
sional predicts recent use of treatment from a mental health
professional, suggesting that women turn to treatment from
individuals with whom they are most familiar.20
In contrast to previous research that found lower rates of
mental health treatment use among African American indi-
viduals,6,7 there were no significant differences in formal
mental health treatment use between African American and
white women in this study. This discrepancy may be due to
the availability of mental healthcare clinicians in the clinics
from which the women were recruited. The urban clinics,
where many of the African American women were recruited,
routinely screened for depression in pregnant women. Those
women who met clinic criteria for depression risk were then
asked to speak with an on-site social worker, who discussed
their mood with them and provided them with treatment re-
ferrals. Thus, the results regarding formal mental health
treatment use in African American women may not be gen-
eralizable to clinics without exposure to these resources. It
is notable that despite implementation of screening and reg-
ular follow-up with African American women, overall rates
of treatment use remained low, suggesting that additional
treatment engagement efforts may be warranted.
Women, regardless of race, reported that they were most
likely to have used informal treatment, such as seeking ad-
vice and support from friends and family or from printed
material. These findings are consistent with research sug-
gesting that distressed individuals often turn first to infor-
mal forms of treatment.41,42 Psychoeducational or brief ther-
apeutic strategies that improve family and friend support
among mildly symptomatic women may be highly accept-
able to women. Notably, African American and white
women used different types of informal treatment. Consis-
tent with emerging literature on the importance of religion
in the African American community,43 African American
women were more likely than white women to have spoken
to a religious leader about their mood.
Women reported they had greatest confidence in psy-
chotherapy and support received from family and friends
and least confidence in antidepressant medication and case
management as forms of treatment. African American
women expressed significantly more doubt about antide-
pressant medication than did white women. Recent studies
that provided psychoeducation about antidepressants and
their efficacy in nonpregnant or breastfeeding depressed
populations have found that these brief interventions have
improved willingness to take antidepressants.44 Given
emerging conflicting data on the safety of antidepressants
during pregnancy9,10 and the existence of efficacious psy-
chotherapies, however, it is also important to improve preg-
nant women’s awareness of and access to psychotherapy as
a treatment option. Efforts at improving psychoeducation
about antidepressants and the availability of therapy may be
particularly important for African American women.
Women in this study expressed greatest confidence in
mental health specialists, the provider type with whom they
were least likely to have had any form of contact. Given that
access and familiarity are linked to provider use, improving
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access to mental health providers, such as having on-site
mental health clinicians, may improve women’s use of men-
tal health professionals. Religious leaders also received high
levels of confidence, particularly among African American
women. Such results suggest that training religious leaders
in depression-specific psychotherapies may be an especially
effective way of reaching a broader range of women in need
of treatment.
The perinatal period may present unique difficulties to ac-
cessing treatments in traditional locales (e.g., a professional
office). A number of depression treatment outcome studies
have attempted to remedy access problems by delivering
treatment in the home,45 over the internet,46 in supermar-
kets,47 or via telephone.48 It is less clear how women per-
ceive these different forms of treatment delivery. In the pres-
ent study, women indicated that they had greatest
confidence in treatments delivered in a professional office,
followed by treatments delivered at home. They reported in-
termediate levels of confidence in treatments delivered over
the telephone and in religious settings, although African
American women expressed greater confidence than did
white women in treatment delivered in a religious setting.
Community settings and the internet were endorsed with the
least amount of confidence. African American women ex-
pressed particularly low levels of confidence in treatment de-
livered via the internet.
Although women’s beliefs about treatment may serve as
prompts to seek out treatment, it is also important to know
what factors act as barriers to treatment use. In this study,
women were significantly more concerned with structural
barriers than with either knowledge or attitudinal barriers.
There were no significant differences in African American
and white women’s perceived barriers, suggesting that both
groups of women are concerned about similar difficulties in
accessing treatment. These results point to important areas
of concern for women that may be addressed through both
system and individual level changes. For instance, improved
education (e.g., making women aware of treatment payment
options) and changes in treatment delivery to offset struc-
tural barriers (e.g., providing treatment via telephone in or-
der to overcome transportation and child care concerns) may
help to address women’s barriers and improve their will-
ingness to use treatment.
Limitations
Corroborating data about the specific forms and intensity
of formal treatment were not gathered in this study. Related
research in this area has found that treatment is often marked
by low dose (e.g., low medication dose49), low number of at-
tended therapy sessions,50 and poor adherence,51 suggesting
that some of the women in this study may have received sub-
optimal treatment. Future studies that gather medical record
and pharmacy information, in addition to participant re-
sponses about number of sessions attended, medications pre-
scribed, and prescriptions filled, may provide better distinc-
tions between simple treatment use and the receipt of
efficacious treatment.
The lack of available longitudinal data in this study lim-
its conclusions about the impact of women’s beliefs and per-
ceived barriers on their treatment use over time and, ulti-
mately, on their depression outcomes. However, previous
research has demonstrated that beliefs about treatment and
perceived barriers are important determinants of both will-
ingness to seek treatment and delays in actually engaging in
treatment.14,26 It is possible that women’s confidence in treat-
ment type may vary between those who sought treatment
and those who did not. The low number of participants in
this study precluded such examinations, however. Future re-
search with larger samples is needed to examine factors im-
pacting women’s beliefs about treatment, including possible
differences across broader racial groups.
It is possible that some of the perceived barriers assessed
in this study may be unique to the perinatal period or, more
specifically, pregnancy. Longitudinal and cross-sectional re-
search examining differences in perceived barriers to treat-
ment in women during the perinatal period and other peri-
ods of life are needed, in addition to comparisons between
pregnant and nonpregnant women.
Differences in administering the interview over the tele-
phone or in person may have introduced a bias in women’s
responses. Previous research, however, has found no signif-
icant differences in the validity of psychiatric interviews de-
livered via telephone or in person.52,53
Finally, although this study consisted of a relatively bal-
anced racial and socioeconomic sample, the rate of attrition
was somewhat high. Notably, African American women
were more likely to complete the interview than were white
women. Such rates of attrition are consistent with previous
research with lower-income, community, and clinic sam-
ples39,40 and reflect difficulties in conducting research with
multiply stressed individuals.
This study provides initial data suggesting that women
have identifiable beliefs about treatment, and these beliefs
vary in important ways across African American and white
women. Given low rates of treatment use among depressed
women, it is important to improve education about treat-
ment options as well as the effectiveness of available treat-
ments. Understanding women’s beliefs about treatment and
their perceived barriers to treatment provides a basis for cus-
tomizing treatment based on their expectancies and needs
and, ultimately, improving treatment use. Additional re-
search investigating women’s beliefs may help to guide the
ways in which treatment referrals and delivery are con-
ducted to better meet women’s needs and the use of mental
health treatment.
Disclosure Statement
No competing financial interests exist.
References
1. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal de-
pression: Prevalence, screening accuracy, and screening out-
comes. Evid Rep Technol Assess (Summ) 2005;119:1–8.
2. Breslau J, Kendler K, Maxwell S, et al. Lifetime risk and per-
sistence of psychiatric disorders across ethnic groups in the
United States. Psychol Med 2005;35:317–320.
3. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of
response to psychotherapy and pharmacotherapy: Findings
in the NIMH Treatment of Depression Collaborative Re-
search Program. Am J Psychiatry 1991;148:997–1008.
4. Weinberger J, Eig A. Expectancies: The ignored common fac-
tor in psychotherapy. In: Kirsch I, ed. How expectancies
PROMPTS AND BARRIERS TO PERINATAL DEPRESSION TREATMENT 1307
shape experience. Washington, DC: American Psychological
Association, 1999:357–382.
5. Flynn HA, O’Mahen HA, Massey L, Marcus S. The impact
of a brief obstetrics clinic-based intervention on treatment
use for perinatal depression. J Womens Health 2006;15:1195–
1204.
6. Carrington CH. Clinical depression in African American
women: Diagnoses, treatment, and research. J Clin Psychol
2006;62:779–791.
7. Das AK, Ofson M, McCurtis HL, Weissman MM. Depres-
sion in African Americans: Breaking barriers to detection
and treatment. J Fam Pract 2006;55:30–39.
8. Weissman MM, Pilowsky DJ, Wickramaratne PJ, et al. Re-
missions in maternal depression and child psychopathology:
A STAR*D-child report. JAMA 2006;295:1389–1398.
9. Ferreira E, Carceller AM, Agogue C, et al. Effects of selec-
tive serotonin reuptake inhibitors and venlafaxine during
pregnancy in term and preterm neonates. Pediatrics
2007;119:52–59.
10. Djulus J, Koren G, Einarson TR, et al. Exposure to mirtaza-
pine during pregnancy: A prospective, comparative study
of birth outcomes. J Clin Psychiatry 2006;67:1280–1284.
11. Oberlander TF, Warburton W, Misri S, et al. Neonatal out-
comes after prenatal exposure to selective serotonin reup-
take inhibitor antidepressants and maternal depression us-
ing population-based linked health data. Arch Gen
Psychiatry 2006;63:898–906.
12. Scholle SH, Haskett RF, Hanusa BH, et al. Addressing de-
pression in obstetrics/gynecology practice. Gen Hosp Psy-
chiatry 2003;25:83–90.
13. Simon GE, Ludman EJ, Tutty S, et al. Telephone psy-
chotherapy and telephone care management for primary
care patients starting antidepressant treatment: A random-
ized controlled trial. JAMA 2004;292:935–942.
14. Thompson A, Hunt C, Issakidis C. Why wait? Reasons for
delay and prompts to seek help for mental health problems
in an Australian clinical sample. Soc Psychiatry Psychiatr
Epidemiol 2004;39:810–817.
15. Meyer B, Pilkonis PA, Krupnick JL, et al. Treatment ex-
pectancies, patient alliance, and outcome: Further analyses
from the National Institute of Mental Health Treatment of
Depression Collaborative Research Program. J Consult Clin
Psychol 2002;70:1051–1055.
16. Leaf PJ, Weissman MM, Holzer CE, et al. Contact with health
professionals for the treatment of psychiatric and emotional
problems. Med Care 1985;23:1322–1337.
17. Mojtabai R, Olfson M, Mechanic D. Perceived need and help-
seeking in adults with mood, anxiety, or substance abuse
disorders. Arch Gen Psychiatry 2002;59:77–84.
18. Bayer JK, Peay MY. Predicting intentions to seek help from
professional mental health services. Aust NZ J Psychiatry
1997;31:504–513.
19. Jorm AF, Christensen H, Medway J, et al. Public belief sys-
tems about the helpfulness of interventions for depression:
Associations with history of depression and professional
help-seeking. Soc Psychiatry Psychiatr Epidemiol 2000;35:
211–219.
20. Alvidrez J, Azocar F. Distressed women’s clinic patients:
Preferences for mental health treatments and perceived ob-
stacles. Gen Hosp Psychiatry 1999;21:340–347.
21. Scholle SH, Kelleher K. Preferences for depression advice
among low-income women. Matern Child Health J 2003;7:
95–102.
22. Wang J, Patten SB, Williams JV, et al. Help-seeking behav-
iours of individuals with mood disorders. Can J Psychiatry
2005;50:652–659.
23. Amankwaa LC. Postpartum depression among African-
American women. Issues Ment Health Nurs 2003;24:297–
316.
24. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of
treatment for depression among African-American, His-
panic, and white primary care patients. Med Care 2003;41:
479–489.
25. Newport DJ, Calamaras MR, Devane CL, et al. Atypical an-
tipsychotic administration during late pregnancy: Placental
passage and obstetrical outcomes. Am J Psychiatry 2007;164:
1214–1220.
26. Wang PS, Gilman SE, Guardino M, et al. Initiation of and
adherence to treatment for mental disorders: Examination
of patient advocate group members in 11 countries. Med
Care 2000;38:926–936.
27. Sareen J, Jagdeo A, Cox BJ, et al. Perceived barriers to men-
tal health service utilization in the United States, Ontario,
and the Netherlands. Psychiatr Serv 2007;58:357–364.
28. Ojeda VD, McGuire TG. Gender and racial/ethnic differ-
ences in use of outpatient mental health and substance use
services by depressed adults. Psychiatr Q 2006;77:211–222.
29. Schraufnagel TJ, Wagner AW, Miranda J, Roy-Byrne PP.
Treating minority patients with depression and anxiety:
What does the evidence tell us? Gen Hosp Psychiatry
2006;28:27–36.
30. Boath E, Bradley E, Henshaw C. Women’s views of antide-
pressants in the treatment of postnatal depression. J Psy-
chosom Obstet Gynaecol 2004;25:221–233.
31. Hickey AR, Boyce PM, Ellwood D, Morris-Yates AD. Early
discharge and risk for postnatal depression. Med J Aust
1997;167:244–247.
32. Carter FA, Carter JD, Luty SE, et al. Screening and treatment
for depression during pregnancy: A cautionary note. Aust
NZ J Psychiatry 2005;39:255–261.
33. Cox JL, Holden JM, Sagovsky R. Detection of postnatal de-
pression. Development of the 10-item Edinburgh Postnatal
Depression Scale. Br J Psychiatry 1987;150:782–786.
34. Hankin BL, Abramson LY. Development of gender differ-
ences in depression: An elaborated cognitive vulnerability-
transactional stress theory. Psychol Bull 2001;127:773–796.
35. Leskela U, Rytsala H, Komulainen E, et al. The influence of
adversity and perceived social support on the outcome of
major depressive disorder in subjects with different levels
of depressive symptoms. Psychol Med 2006;36:779–788.
36. Adouard F, Glangeaud-Freudenthal NM, Golse B. Valida-
tion of the Edinburgh Postnatal Depression Scale (EPDS) in
a sample of women with high-risk pregnancies in France.
Arch Womens Ment Health 2005;8:89–95.
37. Horowitz JA, Goodman J. A longitudinal study of maternal
postpartum depression symptoms. Res Theory Nurs Pract
2004;18:149–163.
38. McCoy SJ, Beal JM, Shipman SB, et al. Risk factors for post-
partum depression: A retrospective investigation at 4-weeks
postnatal and a review of the literature. J Am Osteopath As-
soc 2006;106:193–198.
39. Hobfoll SE, Ritter C, Lavin J, et al. Depression prevalence
and incidence among inner-city pregnant and postpartum
women. J Consult Clin Psychol 1995;63:445–453.
40. Miranda J, Green BL, Krupnick JL, et al. One-year outcomes
of a randomized clinical trial treating depression in low-in-
come minority women. J Consult Clin Psychol 2006;74:99–
111.
41. Jorm AF, Christensen H, Griffiths KM. The impact of be-
yondblue: The national depression initiative on the Aus-
tralian public’s recognition of depression and beliefs about
treatments. Aust NZ J Psychiatry 2006;40:42–46.
O’MAHEN AND FLYNN1308
42. Jorm AF, Mackinnon A, Christensen H, Griffiths KM. Struc-
ture of beliefs about the helpfulness of interventions for de-
pression and schizophrenia. Results from a national survey
of the Australian public. Soc Psychiatry Psychiatr Epidemiol
2005;40:877–883.
43. Musgrave CF, Allen CE, Allen GJ. Spirituality and health for
women of color. Am J Public Health 2002;92:557–560.
44. Bonari L, Koren G, Einarson TR, et al. Use of antidepres-
sants by pregnant women: Evaluation of perception of risk,
efficacy of evidence based counseling and determinants of
decision making. Arch Womens Ment Health 2005;8:214–
220.
45. Chabrol H, Teissedre F, Saint-Jean M, et al. Prevention and
treatment of post-partum depression: A controlled random-
ized study on women at risk. Psychol Med 2002;32:1039–
1047.
46. Griffiths KM, Christensen H, Jorm AF, et al. Effect of web-
based depression literacy and cognitive-behavioural therapy
interventions on stigmatising attitudes to depression: Ran-
domised controlled trial. Br J Psychiatry 2004;185:342–349.
47. Swartz HA, Shear MK, Frank E, et al. A pilot study of com-
munity mental health care for depression in a supermarket
setting. Psychiatr Serv 2002;53:1132–1137.
48. Mohr DC, Hart SL, Julian L, et al. Telephone-administered
psychotherapy for depression. Arch Gen Psychiatry
2005;62:1007–1014.
49. Melfi CA, Croghan TW, Hanna MP. Access to treatment for
depression in a Medicaid population. J Health Care Poor Un-
derserved 1999;10:201–215.
50. Croghan TW, Lair TJ, Engelhart L, et al. Effect of antide-
pressant therapy on health care utilization and costs in pri-
mary care. Psychiatr Serv 1997;48:1420–1426.
51. Vergouwen AC, Bakker A, Katon WJ, et al. Improving ad-
herence to antidepressants: A systematic review of inter-
ventions. J Clin Psychiatry 2003;64:1415–1420.
52. Wells KB, Stewart A, Hays RD, et al. The functioning and
well-being of depressed patients. Results from the Medical
Outcomes Study. JAMA 1989;262:914–919.
53. Hermens ML, Ader HJ, van Hout HP, et al. Administering
the MADRS by telephone or face-to-face: A validity study.
Ann Gen Psychiatry 2006;22:3.








PROMPTS AND BARRIERS TO PERINATAL DEPRESSION TREATMENT 1309
Appendix: Barriers Scale
“To what extent do the following factors prevent you from seeking treatment?”
Structural barriers
1. Insurance does not cover
2. Inability to pay
3. Inadequate child care
4. Transportation
5. Distance to travel to clinic
Knowledge barriers
1. Do not have time
2. Not sure who to contact
3. Not sure how to set up an appointment
4. Do not know what treatment might be best for me
Attitudinal barriers
1. Worried about what others will think
2. Do not think I can be helped effectively
3. My family does not support my getting treatment
4. It is difficult to become motivated to seek treatment
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